Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Raymond James Financial (NY: RJF )

165.18 +1.40 (+0.85%)
Official Closing Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Raymond James Financial

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
3 Stocks to Dump Before They Dive
Investors should stay away from these stocks to sell, since they don't really offer any upside at the moment. 
Via InvestorPlace
Raymond James Maintains Outperform Rating for Accolade: Here's What You Need To Know
Via Benzinga
FOUNDATION WEALTH STRATEGIES, LLC. OF WHEATON, IL BENEFITS MIDWEST SHELTER FOR HOMELESS VETERANS
Via Viz Release
Topics Retirement
Exposures Pension
Why American Coastal Insurance Stock Dived by 17% Today
A dilutive new equity issue sent investors scrambling for the exits. 
Via The Motley Fool
Raymond James Maintains Outperform Rating for Delek US Hldgs: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga
Where Raymond James Finl Stands With Analysts
Via Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37... 
Via Benzinga
Dow Jones Stock Upgraded After Big Week; Poised To Snap Downtrend
Raymond James initiated coverage of Disney stock with a buy rating as the "premier" streaming play. Dow Jones giant poised to snap downtrend. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why DexCom Stock Dove by 5% Today
A note from an increasingly cautious pundit may have created a downdraft for this high-flying glucose monitor company. 
Via The Motley Fool
Raymond James Maintains Outperform Rating for Darden Restaurants: Here's What You Need To Know
Via Benzinga
Raymond James Maintains Outperform Rating for Phreesia: Here's What You Need To Know
Via Benzinga
A Preview Of Raymond James Finl's Earnings
Via Benzinga
Expert Ratings for Raymond James Finl
Via Benzinga
Unleashing Growth Potential: Raymond James Finl Surpasses Expectations with Strong Performance and Increasing Profits
Via Benzinga
Bank Of America Is Bullish On Raymond James: 'Diversified Approach Shines Through'
In a sector where fluctuating rates often dictate profits, Raymond James Financial (NYSE: RJF) is showing some resilience, underpinned by a diversified profit model that's envied by many of its... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023
Via Benzinga
Why The Toro Company Stock Plummeted by 21% This Week
Investors and analysts both became more bearish on the company over the five-day stretch. 
Via The Motley Fool
Does It Make Sense to Invest in a Company With Its Name on a Stadium?
Look beyond the big print. 
Via The Motley Fool
Analysts Remain Bullish on Snowflake Stock. But Are They Right?
The stock's valuation already prices in massive growth for years to come. 
Via The Motley Fool
Expectations For M&A In Midstream Oil & Gas: Raymond James Downgrades Holly Energy And Crestwood Equity Amid Acquisition Deals
Raymond James analyst Justin Jenkins  
Via Benzinga
Netflix To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Friday
Raymond James lowered the price target for Ulta Beauty, Inc. (NASDAQ: ULTA) from $600 to $550. Raymond James analyst Olivia Tong maintained a Strong Buy rating. Ulta Beauty shares gained 1.5% to... 
Via Benzinga
Raymond James Survey: Investors’ Top Priorities for Safeguarding Generational Wealth
From Raymond James Financial
Via GlobeNewswire
Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock
From Raymond James Financial
Via GlobeNewswire
Wall Street Is Growing Increasingly Bearish on This Ultra-High-Yielding Dividend Stock. A Major Dividend Cut Could Be Imminent.
Medical Properties Trust has seen a barrage of analyst downgrades following its second-quarter results. 
Via The Motley Fool
Raymond James Maintains Outperform Rating for Open Lending: Here's What You Need To Know
Via Benzinga
Raymond James Maintains Outperform Rating for Vivid Seats: Here's What You Need To Know
Via Benzinga
Raymond James Financial Reports Third Quarter of Fiscal 2023 Results
From Raymond James Financial
Via GlobeNewswire
Retail Investors' Bullish Sentiment Fuels Rally In Brokerage Stocks: Standout Performers Of Q2 Earnings Season
Via Benzinga
Why I'm Not Worried About Verizon's 8%-Yielding Dividend
Cable concerns sent the telecom company's stock price down. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.